Table 2.
Compound | Target | Chemical structures | Model |
---|---|---|---|
Erastin (Dolma et al., 2003; Yagoda et al., 2007) |
System xc- and VDAC2/3 | HT-1080 cell BJeLR cell Calu-1 cell |
|
PE (Yang et al., 2014) |
System xc- and VDAC2/3 | HT-1080 cell BJeLR cell DRD cell |
|
IKE (Larraufie et al., 2015) |
System xc- | CCF-STTG1 cell HT-1080 cell BJeH cell BJeHLT cell DRD cell |
|
Sorafenib (Louandre et al., 2013; Louandre et al., 2015) | System xc- mitochondria ROS |
HCC cell | |
Sulfasalazine (Gout et al., 2001) |
System xc- | Nb2-SFJCD1 cell Nb2-U17 rats |
|
Lanperisone (Shaw et al., 2011) |
System xc- | MEFs cell Mox2-Cre mice |
|
RSL3 (Yang et al., 2014) |
GPX4 | HT-1080 cell BJeLR cell BJeHLT cell 4 BJ cell |
|
RSL5 (Yang and Stockwell, 2008) |
VDAC2/3 | BJeH cell BJeHLT cell BJeLR cell |
|
BSO (Yang et al., 2014) |
GSH depletion | BJeLR cell BJeH cell BJeHLT cell DRD cell |
|
DPI2 (Yang et al., 2014) (class I FINs) |
GSH depletion | BJeLR cell | |
DPI7 (Yang et al., 2014) (class II FINs) |
GPX4 | BJeLR cell | |
Acetaminophen (Lorincz et al., 2015) | GSH depletion | HepG2 cell NMRI mice |
|
Artesunate (Eling et al., 2015) |
GSH depletion | Panc1 cell COLO357 cell AsPC-1 cell BxPC-3 cell 293T cell HPDE cell PDAC cell |
|
FIN56 (Shimada et al., 2016b) |
Promote the degradation of GPX4 Reduce the abundance of CoQ10 |
BJeLR cell DRD cell BJeHLT cell BJeH cell HT-1080 cell 143B cell Calu-1 cell |
|
FINO2 (Gaschler et al., 2018a) |
Oxidize ferrous iron Inactivate GPX4 indirectly |
HT-1080 cell BJ-5ta cell BJeLR cell CAKI-1 cell |
|
Silica-based nanoparticles (Kim et al., 2016) |
GSH depletion and increase iron | M21 cell HT-1080 cell 786-O cell |
|
Cisplatin (Yamaguchi et al., 2013) | GSH depletion | H1299 cell A549 cell PC9 cell |